Physician

Nassim H Nabbout, M.D.

According to 2025 Medicare claims, Nassim Nabbout, M.D. (NPI: 1528029147) practices hematology/oncology in the Wichita, KS market, with the plurality of this provider's patient population coming from Sedgwick, KS. This provider's primary affiliated billing organization is CANCER CENTER OF KANSAS, P.A. (NPI: 1841251394; TIN: 481181579) and primary practice location at 67208-3006. Nabbout is affiliated with the Aledade 38 KS CHC MSSP Enhanced (ACO ID: A4546), Aledade 155 National MSSP (ACO ID: A5358), and Vytalize Health KS 25 LLC (ACO ID: A5671), participating under the MSSP model.

Nabbout's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,353 traditional Medicare patients, billed 475,168 HCPCS/CPT codes, and received $9,007,406 in Medicare payments. The top billing code was 99213 (Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more). Part D data shows 2,946 prescription claims across 449 beneficiaries totaling $6,288,719 in drug costs, led by Jakafi (Ruxolitinib Phosphate). DME data shows 34 claims. Open Payments data shows 208 records totaling $3,311. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $2,866,115 to $9,007,406. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $2,673,463 to $6,288,719. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $15,114 to $2,954.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,045	189,703	$2,866,115
2016	1,038	260,517	$2,992,027
2017	1,096	283,216	$3,203,118
2018	1,135	300,103	$4,081,611
2019	1,174	344,955	$5,299,791
2020	1,141	411,545	$6,300,152
2021	961	406,588	$6,131,995
2022	975	336,797	$5,037,928
2023	1,247	424,823	$6,348,797
2024	1,353	475,168	$9,007,406

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	322	2,582	$2,673,463
2016	344	2,640	$2,610,737
2017	400	2,924	$2,461,540
2018	393	2,838	$3,003,770
2019	446	3,260	$4,742,329
2020	437	3,343	$5,592,865
2021	449	3,054	$4,868,511
2022	449	2,991	$5,484,996
2023	460	2,911	$5,212,302
2024	449	2,946	$6,288,719

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	52	181	$16,296
2016	N/R	130	$10,018
2017	N/R	N/R	N/R
2018	N/R	43	$4,870
2019	N/R	N/R	N/R
2020	11	14	$1,121
2021	N/R	12	$554
2022	N/R	26	$1,866
2023	N/R	38	$10,666
2024	N/R	34	$2,354

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	408	569	$61
80053	Blood test, comprehensive group of blood chemicals	352	1,266	$10
36415	Insertion of needle into vein for collection of blood sample	374	1,644	$9
85027	Complete blood cell count (red cells, white blood cell, platelets), automated test	368	1,594	$6
85007	Microscopic examination for white blood cells with manual cell count	368	1,592	$4

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Jakafi	Ruxolitinib Phosphate	65	1,950	$965,336
Revlimid	Lenalidomide	35	980	$691,285
Calquence	Acalabrutinib Maleate	40	1,200	$626,121
Xtandi	Enzalutamide	31	930	$430,383
Venclexta	Venetoclax	30	944	$314,098

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	11	$1,457
A5063	Ostomy pouch, drainable; for use on barrier with flange (2 piece system), each	N	N/R	12	$636
E0431	Portable gaseous oxygen system, rental; includes portable container, regulator, flowmeter, humidifier, cannula or mask, and tubing	Y	N/R	11	$260

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	208	$3,311	PFIZER INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Nassim H. Nabbout, M.D.?

Tedicare shows public-source Medicare data for Nassim H. Nabbout, M.D. (NPI 1528029147), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Nassim H. Nabbout, M.D. have ACO affiliation data?

Nassim H. Nabbout, M.D. is shown with ACO affiliation data for Aledade 38 KS CHC MSSP Enhanced (MSSP, ACO ID A4546), Aledade 155 National MSSP (MSSP, ACO ID A5358), and Vytalize Health KS 25 LLC (MSSP, ACO ID A5671).

What billing organization is linked to Nassim H. Nabbout, M.D.?

Nassim H. Nabbout, M.D. is linked to CANCER CENTER OF KANSAS, P.A. (billing NPI 1841251394) in the available physician profile data.

Does Nassim H. Nabbout, M.D. have Open Payments data?

Nassim H. Nabbout, M.D. has 208 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.